EHR

Nabla Rolls out at Carle Health Through Epic Integration

U.S. health systems are increasingly embracing ambient documentation solutions to reduce providers' administrative workloads and enable more face time with…

6 months ago

Octagos Health Secures Over $43 Million Investment to Advance AI-Driven Cardiac Device Monitoring

HOUSTON, July 9, 2024 /PRNewswire/ -- Octagos Health, an industry-leading provider of AI-driven cardiac device monitoring solutions, today announced a successful…

6 months ago

Accushield Integrates with August Health EHR to Streamline Data Management

ATLANTA, July 9, 2024 /PRNewswire/ -- Accushield, a leading provider of visitor management solutions for senior living communities, announces a…

6 months ago

New EHR tool empowers dermatologists with comprehensive medication side effects insights

EZDERM's "Side Effects Module" streamlines dermatology exams while increasing patient safetyNAPLES, Fla., July 9, 2024 /PRNewswire/ -- EZDERM, a leading…

6 months ago

Pascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance patient-centric innovation in clinical trial design and market access

One2Treat reflects patient priorities in a single multi-facet treatment assessment, reducing trial sample size and accelerating patient access to new…

6 months ago

Hop on a Cure Makes Financial Contribution Toward ALS CURE Project

ATLANTA, GA / ACCESSWIRE / July 9, 2024 / Hop On A Cure, a leading advocate in the fight against…

6 months ago

DAS Health Expands Into Canadian Market with Recent Acquisition

Tampa, July 09, 2024 (GLOBE NEWSWIRE) -- DAS Health Ventures, LLC (DAS Health), a provider of healthcare IT and business…

6 months ago

Seyltx Announces Results of Electronic Health Record Analysis to Determine the Prevalence of Refractory Chronic Cough

- Data will be presented at the London International Cough Symposium on July 18, 2024 - 54,958,289 adult patients in…

6 months ago

Updates from NurExone: Growth Conference Presentation and Website Relaunch

TORONTO and HAIFA, Israel, July 05, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the…

6 months ago

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) -- Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia…

6 months ago